Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: A long-term follow-up study

Ann Hepatol. 2022 May-Jun;27(3):100683. doi: 10.1016/j.aohep.2022.100683. Epub 2022 Feb 10.

Abstract

Introduction and objectives: De novo malignancies represent an important cause of death for liver transplant recipients. Our aim was to analyze predictors of extra-hepatic non-skin cancer (ESNSC) and the impact of ESNSC on the long-term outcome.

Patients: We examined data from patients transplanted between 2000 and 2005 and followed-up in five Italian transplant clinics with a retrospective observational cohort study. Cox Regression was performed to identify predictors of ESNSC. A 1:2 cohort sub-study was developed to analyze the impact of ESNSC on 10-year survival.

Results: We analyzed data from 367 subjects (median follow-up: 15 years). Patients with ESNSC (n = 47) more often developed post-LT diabetes mellitus (DM) (57.4% versus 35,9%, p = 0.004). At multivariate analysis, post-LT DM independently predicted ESNSC (HR 1.929, CI 1.029-3.616, p = 0.040). Recipients with ESNSC showed a lower 10-year survival than matched controls (46,8% versus 68,1%, p = 0.023).

Conclusions: Post-LT DM seems to be a relevant risk factor for post-LT ESNSC. ESNSC could have a noteworthy impact on the long-term survival of LT recipients.

Keywords: Aging; Cancer; Diabetes; Liver transplant; Metabolic syndrome.

Publication types

  • Observational Study

MeSH terms

  • Diabetes Mellitus* / etiology
  • Follow-Up Studies
  • Humans
  • Liver Neoplasms* / etiology
  • Liver Neoplasms* / surgery
  • Liver Transplantation* / adverse effects
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome